EcoDrugPlus

Ensembl ID : ENSDLAG00005029311
Gene Symbol: -
Cross references: -
134 Possible Orthologues:

Ensembl ID : ENSDLAG00005029929
Gene Symbol: -
Cross references: -
351 Possible Orthologues:

Ensembl ID : ENSDLAG00005030011
Gene Symbol: -
Cross references: -
498 Possible Orthologues:

Ensembl ID : ENSDLAG00005030438
Gene Symbol: -
Cross references: -
231 Possible Orthologues:

Ensembl ID : ENSDLAG00005031109
Gene Symbol: -
Cross references: -
338 Possible Orthologues:

Ensembl ID : ENSDLAG00005031134
Gene Symbol: -
Cross references: -
189 Possible Orthologues:

Ensembl ID : ENSDLAG00005031385
Gene Symbol: -
Cross references: -
151 Possible Orthologues:

Ensembl ID : ENSDLAG00005031629
Gene Symbol: -
Cross references: -
181 Possible Orthologues:

Ensembl ID : ENSDLAG00005031627
Gene Symbol: -
Cross references: -
383 Possible Orthologues:

Ensembl ID : ENSDLAG00005031660
Gene Symbol: -
Cross references: -
187 Possible Orthologues:

Ensembl ID : ENSDLAG00005032181
Gene Symbol: -
Cross references: -
198 Possible Orthologues:

Ensembl ID : ENSDLAG00005032243
Gene Symbol: -
Cross references: -
214 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).